Nankai Chemical Company,Limited (TYO:4040)
Japan · Delayed Price · Currency is JPY 3,455.00
-85.00 (-2.40%)
Mar 6, 2026, 11:15 AM JST
TYO:4040 Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 21,053 | 20,900 | 19,987 | 19,601 | 17,434 | 16,463 | |
Revenue Growth (YoY) | 4.17% | 4.57% | 1.97% | 12.43% | 5.90% | 16.28% |
Cost of Revenue | 15,403 | 15,388 | 14,482 | 15,096 | 13,306 | 12,594 |
Gross Profit | 5,650 | 5,512 | 5,505 | 4,505 | 4,128 | 3,869 |
Selling, General & Admin | 4,278 | 4,206 | 3,940 | 3,708 | 3,388 | 3,138 |
Operating Expenses | 4,278 | 4,206 | 3,940 | 3,708 | 3,388 | 3,138 |
Operating Income | 1,372 | 1,306 | 1,565 | 797 | 740 | 731 |
Interest Expense | -71 | -65 | -43 | -42 | -46 | -52 |
Interest & Investment Income | 20 | 29 | 23 | 14 | 10 | 7 |
Earnings From Equity Investments | 25 | 18 | 28 | 30 | -30 | -13 |
Currency Exchange Gain (Loss) | - | - | - | 30 | 35 | - |
Other Non Operating Income (Expenses) | 65 | 167 | 207 | 30 | 6 | 35 |
EBT Excluding Unusual Items | 1,411 | 1,455 | 1,780 | 859 | 715 | 708 |
Gain (Loss) on Sale of Investments | - | 11 | 76 | - | - | 12 |
Gain (Loss) on Sale of Assets | 2,534 | 15 | - | 30 | 529 | -23 |
Asset Writedown | -199 | -193 | -194 | -154 | -333 | -241 |
Other Unusual Items | -5 | 58 | -1 | -72 | -448 | -387 |
Pretax Income | 3,741 | 1,346 | 1,661 | 663 | 463 | 69 |
Income Tax Expense | 1,085 | 296 | 484 | 153 | -9 | -85 |
Earnings From Continuing Operations | 2,656 | 1,050 | 1,177 | 510 | 472 | 154 |
Net Income to Company | - | 1,050 | 1,177 | 510 | 472 | 154 |
Minority Interest in Earnings | -36 | -35 | -19 | -6 | -10 | 1 |
Net Income | 2,620 | 1,015 | 1,158 | 504 | 462 | 155 |
Net Income to Common | 2,620 | 1,015 | 1,158 | 504 | 462 | 155 |
Net Income Growth | 182.33% | -12.35% | 129.76% | 9.09% | 198.06% | 140.66% |
Shares Outstanding (Basic) | 2 | 2 | 2 | 1 | 1 | 1 |
Shares Outstanding (Diluted) | 2 | 2 | 2 | 1 | 1 | 1 |
Shares Change (YoY) | 0.04% | 0.27% | 56.67% | - | 21.31% | - |
EPS (Basic) | 1297.48 | 505.55 | 586.41 | 391.90 | 359.24 | 146.21 |
EPS (Diluted) | 1288.34 | 502.64 | 575.01 | 391.90 | 359.24 | 146.21 |
EPS Growth | 182.35% | -12.59% | 46.72% | 9.09% | 145.70% | - |
Free Cash Flow | - | -1,854 | 587 | 152 | - | - |
Free Cash Flow Per Share | - | -917.69 | 291.33 | 118.19 | - | - |
Dividend Per Share | 35.000 | 55.000 | 50.000 | 15.000 | 15.000 | - |
Dividend Growth | -36.36% | 10.00% | 233.33% | - | - | - |
Gross Margin | 26.84% | 26.37% | 27.54% | 22.98% | 23.68% | 23.50% |
Operating Margin | 6.52% | 6.25% | 7.83% | 4.07% | 4.25% | 4.44% |
Profit Margin | 12.45% | 4.86% | 5.79% | 2.57% | 2.65% | 0.94% |
Free Cash Flow Margin | - | -8.87% | 2.94% | 0.78% | - | - |
EBITDA | 2,594 | 2,442 | 2,587 | 1,802 | - | - |
EBITDA Margin | 12.32% | 11.68% | 12.94% | 9.19% | - | - |
D&A For EBITDA | 1,222 | 1,136 | 1,022 | 1,005 | - | - |
EBIT | 1,372 | 1,306 | 1,565 | 797 | 740 | 731 |
EBIT Margin | 6.52% | 6.25% | 7.83% | 4.07% | 4.25% | 4.44% |
Effective Tax Rate | 29.00% | 21.99% | 29.14% | 23.08% | - | - |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.